James C. Hamilton, Chief Medical Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 20,000 shares at $35.00 ($700K) on 2025-10-01, disclosed to the SEC on 2025-10-03.
Scheduled sale ($700k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARWR | SELL | 2026-01-05 | $2.5M | — | Filing → |
| ARWR | SELL | 2025-09-16 | $450K | — | Filing → |
| ARWR | SELL | 2025-09-04 | $375K | — | Filing → |